A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression

Clinical trial NCT00141271 · COMPLETED

Trial details

NCT number: NCT00141271
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2005-07-01
Primary completion: 2008-02-01
Enrollment: 536

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.